Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. With international facilities and a global distribution network, Zymo Research enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world. While the company provides some of the most technologically advanced products in the industry, everything is driven by the fundamental belief that “the beauty of science is to make things simple.”
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology is a leading biotechnology company specializing in protein engineering and directed evolution technology. Since its establishment in 2014, Yeasen has been dedicated to the advancement of molecular enzymes and proteins within the life science sector. Leveraging our proprietary materials, we have undertaken the development of enzyme and reagents across three key categories: molecules, proteins, and cellular biology. These products cater to the demands of the life science research, molecular diagnostics, and biopharmaceutical industries. Over more than 10 years, Yeasen has evolved into a distinguished international high-tech enterprise, boasting self-reliant research and development as well as manufacturing capabilities.
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. (Stock Code: 668765) is a molecular pharmaceutical company specializing in the development, manufacturing, and marketing of recombinant proteins. Using its proprietary OryzHiExp platform, Healthgen achieves high-yield expression of proteins and peptides in rice grains. Its flagship product, Recombinant Human Serum Albumin (OsrHSA), is a critical reagent used in cell culture, medical devices, biopharmaceutical excipients, and cosmetic additives.
Watchmaker Genomics
Watchmaker applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. We combine deep domain expertise in protein engineering with largescale enzyme manufacturing to address the demanding quality, performance, and scale requirements of clinical genomics applications.
Watchmaker Genomics
Watchmaker applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. We combine deep domain expertise in protein engineering with largescale enzyme manufacturing to address the demanding quality, performance, and scale requirements of clinical genomics applications.
Vivlion
At Vivlion we specialize in CRISPR screening solutions — including combinatorial formats — built for high-resolution mapping of cancer dependencies. CRISPR screening is a powerful tool to interrogate the genome to see what drives tumor growth drug resistance or immune escape. Whether you’re exploring novel targets validating synthetic lethal interactions or identifying biomarkers for patient stratification — CRISPR screens can reveal the functional insights you need to move faster and smarter through the pipeline.
VectorBuilder Inc.
VectorBuilder is a revolutionary online platform that provides researchers with a one-stop solution for all vector design, custom cloning, and virus packaging needs. VectorBuilder also offers many molecular biology services such as stable cell line generation, library construction, and exceptional GMP facilities for a wide range of clinical applications.
US Biolab
US Biolab is a global biobank providing access to a wide variety of human biospecimens, covering healthy and multiple disease states to support researchers’ projects. We offer comprehensive molecular pathology services, including tissue processing, fixation, embedding, sectioning, H&E staining, custom tissue arrays, immunohistochemistry (IHC), special staining, in situ hybridization (ISH), microdissection, DNA and RNA extraction, digital pathology services, polymerase chain reaction (PCR), next-generation sequencing (NGS), and more.
University of Minnesota Genomics Center
The University of Minnesota Genomics Center (UMGC) supports academic and industry scientists worldwide by providing access to advanced genomic technologies and services. Leveraging the latest sequencing platforms, UMGC offers comprehensive end-to-end services that span the entire workflow, from extraction to data delivery, with flexible pricing tiers to accommodate a range of budgets and timelines. Our team of expert scientists brings extensive hands-on experience with complex instrumentation, ensuring reliable results and robust data quality. Supported by scalable infrastructure, UMGC is equipped to handle projects of any scope, from small pilot studies, such as preliminary gene expression analyses, to large-scale initiatives involving the sequencing of thousands of human genomes.